Obesity is associated with increased storage of lipids in nonadipose tissues like skeletal muscle, liver, and pancreatic b cells. These lipids constitute a continuous source of long-chain fatty acyl CoA (LC-CoA) and derived metabolites like diacylglycerol and ceramide, acting as signalling molecules on protein kinases activities (in particular, the family of PKCs), ion channel, gene expression, and protein acylation. In skeletal muscle, the increase in LC-CoA and diacylglycerol translocates and activates specific protein kinase C (PKC) isoforms, which will phosphorylate IRS-1 on serine, preventing its phosphorylation on tyrosine and association with PI3 kinase. This interrupts the insulin signalling pathway leading to the stimulation of glucose transport. In pancreatic b cells, short-term excess of fatty acids or LC-CoA activates PKC and also directly stimulates insulin exocytosis. Longterm exposure to free fatty acids (FFA) leads to an increased basal and blunted glucose-stimulated insulin secretion by affecting gene expression, increase in K ATP channel activity, and uncoupling of the mitochondria. In addition, the saturated FFA palmitate increases cell death by apoptosis via increase in ceramide synthesis.
Introduction
Insulin resistance is a pathological state in which target tissues, mainly skeletal muscle, fail to respond to normal levels of insulin to increase glucose uptake. In most situations, pancreatic b cells can compensate by increasing insulin secretion in order to maintain normoglycemia. As insulin resistance aggravates, more insulin is required to maintain glycemia, the pancreatic b cells cannot fully compensate and impaired glucose tolerance develops, leading to type 2 diabetes. The events leading to failure of the pancreatic b cells remain unknown and may have genetic components. In humans, as in animal studies there is evidence that excess fatty acids and triglycerides play a key role in the abnormal insulin action and insulin secretion and that they may be the common factor producing gradually and tissue specifically the alterations observed in insulin resistance and type 2 diabetes (reviewed in McGarry  1 and   Boden and Carnell   2 ). Emerging evidence from the last few years indicate that fatty acids and their derivatives act not only as metabolic substrates but mainly as signalling molecules that interact with insulin signalling and secretion. Thus, long-chain fatty acyl-CoA (LC-CoA) derived from plasma fatty acids or from intracellular triglycerides act on protein kinase(s) activity, ion channel, reactive oxygen species (ROS) production, protein acylation, and gene expression. This presentation will review the current knowledge of the mechanisms linking excess lipid supply and content to insulin action in skeletal muscle, and to changes in insulin secretion in the pancreatic b cell.
Short-term effects of fatty acids on insulin secretion
Fatty acids exert dual effects on insulin secretion: in vitro and in vivo studies demonstrate that acute exposure of b cells to free fatty acids (FFA) increases glucose-stimulated insulin secretion (GSIS). It should be mentioned that FFA are the main metabolic substrate of the unstimulated pancreatic b cell 3 and several studies in human and in rodents demonstrate that FFA are essential to maintain insulin secretion during fasting. 4, 5 Administration of intralipid and heparin to raise plasma FFA results in an increased GSIS. 6, 7 Experiments performed on perfused pancreas indicate that the insulinotropic action of FFA increases with their chain length and degree of saturation. 8 In contrast, long-term exposure to FFA increases basal and blunts GSIS.
The mechanism of GSIS involves glucose transport and phosphorylation by the high K m enzyme glucokinase (the glucose sensor). Metabolism of glucose-6-phosphate through glycolysis and pyruvate oxidation elevates the ATP/ADP ratio, which in turn closes the K ATP channel, leading to depolarisation of the cell membrane, opening of the voltagesensitive Ca 2 þ channels, increased Ca 2 þ entry, and exocytosis of insulin granules. These events however do not account for all the effects of glucose. Additional mechanisms link glucose metabolism to insulin secretion in a K ATPindependent and Ca 2 þ -dependent or -independent manner.
Among these mechanisms, increase in malonyl-CoA derived from glucose metabolism inhibits CPT-1, the rate-limiting step in fatty acid oxidation. 9 LC-CoA then accumulate in the cytosol where they may also be used as a precursor for diacylglycerol or phosphatidic acid synthesis. Various combinations of the three signalling molecules may then activate specific protein kinase C (PKC) isoforms. 10 LC-CoA may also directly stimulate exocytosis. 11 Thus, malonyl-CoA and LCCoA increase within minutes after glucose addition in a pancreatic b-cell line. 12 Addition of exogenous FFA may amplify this effect by providing more LC-CoA. Other evidences for an effect of FFA are provided by experiments showing that they also increase KCl and amino-acid-induced insulin secretion. 11 As KCl acts directly on the plasma membrane to depolarize it, one can conclude that fatty acids or their derivatives act on very distal step(s) of the stimulus-secretion coupling, which is compatible with an effect on exocytosis. 11s Alternatively, FFA could also potentiate GSIS by binding to GPR40, a G-coupled receptor recently described. 13 This receptor is highly expressed in pancreatic b cells, functions as a receptor for long-chain fatty acids and increases GSIS in a Ca 2 þ -dependent manner.
Long-term effects of fatty acids on insulin secretion and pancreatic cell death
Prolonged exposure of pancreatic b cells to high levels of FFA (424 h. in vitro, still debated in vivo) increases insulin secretion at low glucose level and markedly attenuates GSIS. Recent data obtained in rodent and human pancreatic islets, as well as in b-cell lines, indicate that FFA, in particular palmitic acid, also decrease b-cell number, essentially by accelerating cell death. It should be mentioned that evidence accumulates indicating that loss of b cells may also occur in type 2 diabetes. Thus, recent studies report a decreased b-cell mass and evidences of increased apoptosis in autopsies from type 2 diabetic patients compared to appropriate control. 14 The decreased b-cell mass and function resulting from longtime exposure to fatty acid is referred to as 'lipotoxicity'.
Numerous studies investigated how long-term fatty acid exposure leads to b-cell dysfunction and apoptosis and several mechanisms are proposed. The contribution of each of them to the loss of b-cell function as well as their relevance to type 2 diabetes is still unknown.
Long-term FFA exposure may alter the expression of genes coding for enzymes playing a critical role in glucose metabolism. Thus, FFA exposure increased the activity of the high K m hexokinase. 15 This could shift glucose responsiveness to lower glucose concentrations and contribute to the high insulin secretion at low glucose. FFA also decrease the expression of acetyl CoA carboxylase (and malonyl CoA level) and increase that of CPT-1, this increases fatty acid oxidation. 16 Long-term exposure to FFA could modify GSIS by uncoupling the mitochondria and decreasing ATP production. As seen above, glucose-induced change in ATP/ADP ratio plays a crucial role in the coupling of glucose metabolism to insulin secretion and any factor uncoupling ATP formation from substrate oxidation will decrease GSIS. The pancreatic b cells express the uncoupling protein UCP2 and fatty acid increase its expression and partly uncouple the b cells. 17 FFA also decrease insulin gene transcription and insulin biosynthesis. 18 Other mechanisms have been proposed to explain the long-term effect of FFA on GSIS: LC-CoA may activate the K ATP channel and hyperpolarize the b cell, rendering its depolarization by glucose more difficult. Among all the fatty acid studied in vitro on human and rodents pancreatic islets, the saturated palmitic acid rapidly induces b-cell apoptosis and reduces their proliferative capacity. 24, 25 Increased levels of palmitic acid correlate with de novo synthesis of ceramides, known to activate the apoptotic pathway in several cell types, including the b cells. The unsaturated oleic acid prevented apoptosis induced by palmitate, probably by mediating upregulation of the antiapoptotic protein bcl-2. 24 Thus, excessive supply of fatty acids greatly affects b-cell function. In addition, depending on their nature, these fatty acids may play a crucial role in the determination of b-cell mass (Table 1) .
It is tempting to speculate that the short-term effect of FFA on insulin secretion has analogy with the situation of insulin resistance prevailing in obesity, and the long-term effect represents the transition between insulin resistance and glucose intolerance leading to overt diabetes, but there is no evidence for that up to now.
Triglyceride content and insulin action in skeletal muscle
In skeletal muscle, excessive fatty acid supply was first shown to decrease insulin-stimulated glucose uptake through Fat storage in pancreas and in insulin-sensitive tissues F Assimacopoulos-Jeannet metabolic interactions leading to decreased glucose oxidation, accumulation of glucose-6-phosphate, which in turn inhibits hexokinase and glucose transport/phosphorylation. 26 The ability of FFA to reduce insulin-stimulated glucose disposal has been confirmed in humans and rodents. In human studies, infusion of FFA during euglycemic hyperinsulinemic clamp induced a rapid decrease in glucose oxidation, while insulin action was modified after several hours and was associated with a decrease in glucose-6-phosphate. According to these data, the initial defect may rather be at the level of glucose transport/phosphorylation, 27 rather than glucose metabolism (Figure 1) . Therefore, fatty acids may not induce insulin resistance by acting as a metabolic substrate competing with glucose oxidation as proposed initially, but may interfere with insulin signalling.
It is now recognized that muscle lipid content, in particular intramyocellular lipids (IMCL), correlate better with insulin resistance than plasma FFA. High IMCL is not only associated with insulin resistance in obese and type 2 diabetic patients but also with lower insulin-stimulated glucose disposal rate in persons at risk like lean offspring of two parents with type 2 diabetes, and in insulin resistance induced by lipid infusion (reviewed in Kelley et al 28 ) . A similar association was observed in rodents using different approaches to alter muscle lipid content:
in transgenic mice overexpressing lipoprotein lipase in skeletal muscle 29 in rats fed a high fat diet 30 in rats given etomoxir, an inhibitor of CPT-1, the rate limiting step in fatty acid oxidation. 31 In contrast, prevention of muscle lipid accumulation is associated with improved insulin sensitivity. Thus, fatty acid translocase CD36-null mice have reduced fatty acid uptake and increased insulin sensitivity, despite high levels of plasma FFA. 32 Similarly, dietary fat withdrawal and physical exercise in rodents reduced both intracellular lipids and insulin resistance. 30 A reduction of lipid accumulation in skeletal muscle may be one of the insulin-sensitizing mechanisms of thiazolidinediones. 33 Excessive accumulation of intramuscular triglycerides may result from increased uptake of circulating FFA, and/or reduced oxidation. Evidence for both has been published: skeletal muscle from high fat fed normal rats display an increased efficiency of FFA uptake that could be explained by increased level of mRNA coding for the fatty acid transporter CD36 and for acyl CoA synthase. 34 In contrast, studies on muscle biopsies from patients with type 2 diabetes show impaired mitochondrial oxidative capacity and size. 35 Very recently, similar impairment of mitochondrial activity has been demonstrated in insulin-resistant offspring of patients with type 2 diabetes, suggesting that an inherited defect in mitochondrial oxidative phosphorylation could be a cause of lipid accumulation. 36 Accumulated intramuscular triglycerides may not behave as active molecules. They may rather act as precursors of signalling molecules like LC-CoA, giving rise to diacylglycerol and ceramides. LC-CoA and their derivatives are known activators of PKC isoenzymes, a family of serine threonine kinase. 37 Serine phosphorylation of insulin receptor substrate 1, IRS-1, will prevent its phosphorylation on tyrosine by the insulin receptor tyrosine kinase and further binding and activation of PI3 kinase, two mandatory steps in insulin stimulation of glucose transport. 38, 39 In addition to several studies performed in vitro, these results have been confirmed by in vivo studies. Plasma FFA have been elevated during an euglycemic hyperinsulinemic clamp in rodents 38 and humans. 40 Successive biopsies showed time-dependent changes Figure 1 Proposed mechanism explaining how excess lipid storage affects insulin sensitivity in skeletal muscle.
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in LC-CoA, diacylglycerol, PKC translocation from cytosol to membrane, serine phosphorylation of IRS-1, and decreased PI3 kinase activation. In addition, LC-CoA can also decrease the activity of hexokinase, and thereby decrease glucose transport/phosphorylation. 41 
Conclusion
In obesity, a situation of excess supply and/or decreased oxidation, fatty acid not only accumulate in adipose cells but also in other tissues like skeletal muscle, liver, and pancreatic b cells. Triglycerides are not harmful as such, but are precursors of signalling molecules like LC-CoA, diacylglycerol, ceramides, acting directly or indirectly in skeletal muscle on insulin signalling and glucose uptake, and in pancreatic b cells, on insulin secretion and cell viability.
